- Q1 2024 Aadi Bioscience Inc Earnings Call TranscriptMay 08, 2024$1.84 (-12.80%)Earnings
- Q4 2023 Aadi Bioscience Inc Earnings Call TranscriptMar 13, 2024$2.16 (+11.34%)Earnings
- Aadi Bioscience Inc Investor Conferece Call TranscriptDec 14, 2023
- Aadi Bioscience Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Aadi Bioscience Inc Earnings Call TranscriptNov 08, 2023$4.65 (-3.53%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Aadi Bioscience Inc Earnings Call TranscriptAug 09, 2023$5.44 (-6.85%)Earnings
- Aadi Bioscience Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Aadi Bioscience Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Q1 2023 Aadi Bioscience Inc Earnings Call TranscriptMay 10, 2023$7.08 (-16.61%)Earnings
- Q4 2022 Aadi Bioscience Inc Earnings Call TranscriptMar 28, 2023$6.85 (-5.52%)Earnings
- Q3 2022 Aadi Bioscience Inc Earnings Call TranscriptNov 09, 2022$13.41 (+2.84%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Aadi Bioscience Inc Earnings Call TranscriptAug 10, 2022$13.88 (-1.49%)Earnings
- Q1 2022 Aadi Bioscience Inc Earnings Call TranscriptMay 12, 2022$12.65 (+9.33%)Earnings
- Aadi Bioscience Inc FYARRO Corporate Call TranscriptNov 23, 2021
- Aadi Bioscience Inc at H C Wainwright Precision Oncology Conference (Virtual) TranscriptOct 20, 2021
- Q3 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2020Earnings
- Q2 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020Earnings
- Aerpio Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 24, 2020
- Aerpio Pharmaceuticals, Inc. - Special Call TranscriptJun 12, 2020
- Q4 2019 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 16, 2020Earnings
- Aerpio Pharmaceuticals, Inc. to Discuss the Results from the TIME-2b Study Conference Call TranscriptMar 18, 2019
- Q4 2018 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2019Earnings
Aadi Bioscience Inc at Jefferies Healthcare Conference Transcript
All right. Welcome, everyone, day two 2023 Jefferies healthcare conference. My name is Roger Song, one of the senior biotech analysts here. Next presenting company is Aadi, and we have the CFO and Interim CEO, Scott. Welcome, Scott.
All right. So Roger, thank you for having me today. It's a pleasure to be here to talk to you about Aadi. Obviously, everyone's familiar with the forward-looking statements. So I'll move right into just a quick overall summary of Aadi.
Aadi is a commercial-stage precision oncology company focused on developing and commercializing genetically defined cancers with mTOR pathway alterations -- yeah, alterations in the mTOR pathway genes. We have a commercial product called FYARRO that was approved late in 2021, has been out on the market since February of last year. And it's for the treatment of an ultra-rare sarcoma known as advanced malignant PEComa.
We're very pleased with the launch progress. On our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)